ArticleFrontiers in public health2025
Global, regional, and national burden of acute glomerulonephritis in children and adolescents: 1990-2021 analysis and future projections.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute glomerulonephritis (AGN) remains a significant issue in global health, yet its burden among children and adolescents has not been sufficiently characterized. This study aims to systematically estimate the global, regional, and national burden of AGN, as well as its temporal trends from 1990 to 2021. Methods: This study utilized data from the Global Burden of Disease (GBD) 2021 study, focusing on incidence rates, disability-adjusted life years (DALYs), and mortality among individuals under 20 years of age. Estimated annual percentage changes (EAPCs) were employed to assess temporal trends, and statistical analyses were conducted to examine correlations with the Socio-Demographic Index (SDI). Additionally, we performed decomposition and inequality analyses, along with Bayesian Age-Period-Cohort (BAPC) analyses, to evaluate trends and distributions related to the burden of AGN. Results: From 1990 to 2021, the global burden of AGN among children and adolescents remained significantly high. In 2021, there were approximately 170,584 new cases, representing a decrease compared to earlier years, with an age-standardized incidence rate (ASIR) of 6.47 per 100,000 (95% UI: 4.79-8.45). The EAPC for incidence showed a declining trend of -1.03% (95% CI: -1.15, -0.92). The total number of DALYs associated with AGN was 59,588.50 (95% UI: 32,925.73-79,649.94), with an age-standardized DALY rate of 2.26 per 100,000 (95% UI: 1.25-3.02), demonstrating a significant decline represented by an EAPC of -4.33% (95% CI: -4.46, -4.21). Gender differences were minimal; however, disparities across SDI regions were pronounced, with middle SDI regions exhibiting the highest incidence rate at 8.87 per 100,000, and increasing incidence rates observed in lower-middle and low SDI regions. Notably, China reported the highest number of cases, followed by Brazil and India. Furthermore, absolute inequality among SDI countries improved from 1990 to 2021, while relative inequality intensified during the same period. Conclusion: This study underscores the substantial and evolving burden of AGN among children and adolescents, highlighting the urgent need for targeted public health strategies and interventions to address disparities in disease burden and improve health outcomes in vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.